Prostate cancer drug screening

Details Prostate cancer drug screening Prostate cancer drug screening

C - Chemistry, Metallurgy

12

Q

C12Q 1/68 (2006.01) C12Q 1/02 (2006.01) C12Q 1/66 (2006.01) G01N 33/574 (2006.01)

Patent

CA 2262438

Screening of compounds for activity toward inhibition of prostate cancer cell proliferation is provided. A cell line is employed which can be used in conventional equipment for determining activity of compounds, where the cell line uses a marker whose expression is responsive to therapeutically active compounds.

On décrit le criblage de composés en vue de rechercher chez ceux-ci une activité d'inhibition de la prolifération des cellules du cancer de la prostate. On emploie une lignée cellulaire que l'on peut utiliser dans un matériel classique de détermination de l'activité de composés, dans lequel cette lignée cellulaire utilise un marqueur dont l'expression est sensible à des composés actifs sur le plan thérapeutique.

Affiliated with

Also associated with

Rating

Prostate cancer drug screening does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prostate cancer drug screening, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostate cancer drug screening will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1942848